Dihexa CAS 1401708-83-2: Technical Specifications & Research Overview

Dihexa is a synthetic, angiotensin IV-derived peptidomimetic investigated in preclinical models for its high-affinity interaction with Hepatocyte Growth Factor (HGF) and its receptor c-Met. This technical document details the chemical identification, molecular weight, structural properties, and analytical purity standards required for laboratory evaluation of Dihexa.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Dihexa is a synthetic, angiotensin IV-derived peptidomimetic investigated in preclinical models for its high-affinity interaction with Hepatocyte Growth Factor (HGF) and its receptor c-Met. This technical document details the chemical identification, molecular weight, structural properties, and analytical purity standards required for laboratory evaluation of Dihexa.

Reviewed by PX1 Research scientific team

Key takeaways

  • [Dihexa](/research-peptides/dihexa) (CAS 1401708-83-2) is an oligopeptide-derived peptidomimetic compound with the molecular formula C27H44N4O5 and a molecular weight of approximately 504.66 g/mol.
  • Understanding the physicochemical properties of [Dihexa](/research-peptides/dihexa) (CAS 1401708-83-2) is essential for calculating molar concentrations, preparing stock solutions, and designing controlled in vitro assays.
  • The primary biochemical target of [Dihexa](/research-peptides/dihexa) is the Hepatocyte Growth Factor (HGF) / c-Met receptor system.
  • Preclinical evaluation of [Dihexa](/research-peptides/dihexa) has focused heavily on its capacity to stimulate synaptogenesis and enhance dendritic spine density in primary neuronal cell cultures and organotypic slice preparations.

Dihexa CAS Number and Chemical Identification

Dihexa (CAS 1401708-83-2) is an oligopeptide-derived peptidomimetic compound with the molecular formula C27H44N4O5 and a molecular weight of approximately 504.66 g/mol. Identified chemically as N-hexanoyl-Tyr-Ile-6-aminohexanamide, Dihexa functions in preclinical research as a high-affinity ligand that potentiates Hepatocyte Growth Factor (HGF) activity via the c-Met receptor tyrosine kinase pathway.

When sourcing reagents for molecular biochemistry, verifying the correct CAS registry number ensures researchers receive the precise molecular structure rather than related fragments or analog variants. Dihexa was engineered to overcome the metabolic instability and poor blood-brain barrier permeability characteristic of endogenous hexapeptides such as Angiotensin IV (Ang IV). By incorporating a hydrophobic hexanoyl cap and a modified hexanoic amide tail, the molecule exhibits exceptional metabolic resistance in enzymatic stability assays.

In analytical documentation, Dihexa is cataloged under CAS 1401708-83-2. Research institutions evaluating the compound rely on unambiguous identity confirmation through nuclear magnetic resonance (NMR) spectroscopy, reverse-phase high-performance liquid chromatography (RP-HPLC), and electrospray ionization mass spectrometry (ESI-MS). For laboratory investigations requiring verified reference material, researchers can obtain high-grade Dihexa research peptide accompanied by lot-specific analytical certificates.

Molecular Weight, Formula, and Peptidomimetic Structure

Understanding the physicochemical properties of Dihexa (CAS 1401708-83-2) is essential for calculating molar concentrations, preparing stock solutions, and designing controlled in vitro assays. The compound possesses a monoisotopic mass of 504.33 g/mol and an average molecular weight of 504.66 g/mol. Its molecular structure consists of an N-terminal hexanoyl group linked to a L-tyrosyl-L-isoleucyl dipeptide core, terminating in a 6-aminohexanoic amide moiety.

Unlike standard linear peptides subject to rapid cleavage by aminopeptidases, Dihexa's non-hydrolyzable amide bonds and modified terminal caps impart high structural stability. The lipophilic hexanoyl group increases the logP value of the molecule, enhancing cell membrane permeability during in vitro cellular assays. The structural core preserves the key pharmacophore elements required to bind the target domains of HGF while providing structural protection against proteolytic breakdown.

Researchers conducting structural biology studies utilize the known atomic configuration of Dihexa to model ligand-receptor binding kinetics. Detailed structural coordinates and structural data are integrated into the comprehensive PX1 research repository to assist laboratory teams in modeling molecular dynamics and receptor-ligand docking.

Mechanism of Action: HGF/c-Met Signaling Pathway

The primary biochemical target of Dihexa is the Hepatocyte Growth Factor (HGF) / c-Met receptor system. In native biological systems, HGF is a pleiotropic growth factor that binds the c-Met receptor tyrosine kinase, triggering dimerization, autophosphorylation, and downstream signaling cascades including the Ras-MAPK and PI3K-Akt pathways. Preclinical studies suggest that Dihexa acts as a potent HGF potentiator, stabilizing the active dimeric conformation of HGF and facilitating robust c-Met autoactivation at picomolar concentrations.

In vitro binding assays demonstrate that Dihexa binds to HGF with high affinity ($K_d \approx 10^{-12}\text{ M}$), effectively lowering the threshold of HGF concentration required to activate intracellular phosphorylation cascades. By promoting c-Met dimerization, Dihexa initiates intracellular signaling pathways responsible for focal adhesion, cellular survival, cytoskeletal remodeling, and neurite outgrowth.

Researchers investigating HGF/c-Met receptor activation utilize Dihexa to dissect downstream kinase cascades without relying on full-length recombinant proteins, which often suffer from short half-lives and high lot-to-lot activity variance in culture media.

Synaptogenesis and Neuronal Plasticity in Preclinical Models

Preclinical evaluation of Dihexa has focused heavily on its capacity to stimulate synaptogenesis and enhance dendritic spine density in primary neuronal cell cultures and organotypic slice preparations. In vitro data indicate that incubation of hippocampal neurons with Dihexa leads to a rapid increase in spinogenesis, marked by an elevated expression of postsynaptic density protein 95 (PSD-95) and synaptophysin markers.

Rodent models of cognitive impairment demonstrate that administration of Dihexa correlates with restored dendritic spine density and enhanced long-term potentiation (LTP) in the CA1 region of the hippocampus. The compound's potency in driving synaptic arborization has been documented as significantly higher than that of endogenous neurotrophic factors such as Brain-Derived Neurotrophic Factor (BDNF) on a molar basis in experimental assays.

These cellular structural changes provide a foundation for preclinical studies evaluating synaptogenic signaling models. By inducing functional dendritic spine formation, Dihexa serves as a valuable molecular tool for probing the mechanisms underlying synaptic connectivity, memory formation pathways, and neurodegenerative pathology.

Comparative Analysis: Dihexa vs. Benchmark Neuro-Research Compounds

When selecting compounds for comparative neuroplasticity research, investigators frequently evaluate Dihexa alongside other established research peptides and peptidomimetics. Key candidates include Semax, Selank, and the tissue-protective peptide BPC-157. While all of these agent classes demonstrate central or systemic activity in preclinical models, their molecular mechanisms and target pathways differ substantially.

Semax and Selank are synthetic heptapeptides derived from ACTH and Tuftsin, respectively. They primarily exert effects by modulating neurotrophin expression (such as BDNF and NGF) and influencing monoaminergic and GABAergic neurotransmission. In contrast, Dihexa operates directly on the HGF/c-Met tyrosine kinase axis as a small-molecule peptidomimetic, yielding higher structural stability and distinct downstream signal transduction.

The following matrix outlines the fundamental chemical and operational differences between these primary research tools:

Analytical Purity Verification: HPLC, Mass Spectrometry & Endotoxins

To ensure reproducible experimental results, laboratory compounds must adhere to strict chemical purity parameters. Research compounds provided by PX1 Research undergo rigorous analytical verification, including reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity $\ge 98\%$ and electrospray ionization mass spectrometry (ESI-MS) to confirm molecular weight.

In addition to identity and purity testing, controlling endotoxin levels is crucial for preventing unspecific inflammatory responses in cellular assays. Endotoxins (lipopolysaccharides) present in low-quality synthesis batches can activate Toll-like receptor 4 (TLR4) on microglial or immune cells, masking true biological activity. Every lot of PX1 Research material undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin content remains below strict laboratory limits ($<0.01\text{ EU/mg}$).

Every shipment includes a third-party Certificate of Analysis (COA) cross-referencing lot numbers, verifying that researchers receive pure, fully characterized material synthesized in GMP-compliant, ISO 17025 certified facilities.

Laboratory Reconstitution and Solubilization Protocols

Due to the hydrophobic hexanoyl cap on the Dihexa structure (CAS 1401708-83-2), its solubility profile differs from classic hydrophilic peptides. While soluble in organic solvents such as dimethyl sulfoxide (DMSO) and ethanol, reconstitution directly into aqueous buffers like Phosphate-Buffered Saline (PBS) can result in slow dissolution or incomplete solvation at higher concentrations.

For optimal in vitro preparation, researchers should first solubilize lyophilized Dihexa powder in high-grade DMSO to create a concentrated stock solution (e.g., $10\text{ mM}$). Once fully dissolved, this stock solution can be diluted into culture media or aqueous assay buffers, maintaining final organic solvent concentrations below cellular toxicity thresholds (typically $<0.1\%\text{ v/v}$ DMSO).

For detailed operational steps regarding reconstituting lipophilic and standard research peptides, consult the official PX1 laboratory reconstitution standards guide prior to bench work.

Storage Conditions, Stability, and Handling Guidelines

Proper storage is essential to prevent chemical oxidation, hydrolysis, or aggregation of Dihexa over extended experimental timelines. Lyophilized Dihexa should be stored in a desiccated environment at $-20^\circ\text{C}$ for short-to-medium term storage, or at $-80^\circ\text{C}$ for long-term preservation.

Once reconstituted into liquid stock solutions, Dihexa aliquots should be divided into single-use volumes to prevent repeated freeze-thaw cycles, which can induce physical instability or localized concentration changes. Reconstituted DMSO stock solutions remain stable at $-20^\circ\text{C}$ for several months when protected from light and moisture.

When handling raw powder, laboratories should utilize personal protective equipment (PPE), including nitrile gloves, safety goggles, and a calibrated microbalance inside a chemical fume hood or laminar flow cabinet to ensure precise mass measurement and containment.

Procurement and Institutional Quality Control

Acquiring high-purity reagents for academic, biotechnology, or pharmaceutical research requires suppliers with established quality assurance frameworks. PX1 Research manufactures all compounds in the USA within state-of-the-art facilities, offering complete lot traceability from raw material synthesis to final analytical packaging.

Orders are dispatched with same-day shipping (Monday through Friday) from centralized fulfillment hubs in California and Arizona, minimizing transit times and thermal exposure. Academic laboratories and enterprise facilities requiring bulk quantities or dedicated procurement terms can establish institutional research accounts for streamlined order management.

To explore the complete index of verified peptidomimetics, signaling ligands, and analytical reagents, browse the full catalog of high-purity research compounds.

Frequently Asked Questions

What is the CAS number for Dihexa?

The CAS registry number for Dihexa is 1401708-83-2. This unique identifier specifies the chemical structure N-hexanoyl-Tyr-Ile-6-aminohexanamide.

What is the exact molecular weight and chemical formula of Dihexa?

Dihexa has a chemical formula of C27H44N4O5 and an average molecular weight of 504.66 g/mol (monoisotopic mass of 504.33 g/mol).

What is the molecular sequence or chemical structure of Dihexa?

Dihexa is a synthetic peptidomimetic consisting of N-hexanoyl-L-tyrosyl-L-isoleucyl-6-aminohexanamide. It is capped at the N-terminus with a hexanoyl group and at the C-terminus with a 6-aminohexanoic amide.

How does Dihexa interact with the HGF/c-Met signaling pathway in vitro?

Preclinical data show Dihexa binds to Hepatocyte Growth Factor (HGF) with high affinity (picomolar range), acting as a potentiator that facilitates c-Met receptor dimerization and autophosphorylation.

What analytical testing validates the purity of PX1 Research Dihexa?

PX1 Research verifies each lot of Dihexa via RP-HPLC for purity (minimum 98%), ESI-MS for molecular weight verification, and LAL testing for endotoxin levels (<0.01 EU/mg).

What solvent system is recommended for reconstituting Dihexa in laboratory experiments?

Dihexa is hydrophobic and dissolves best in organic solvents such as DMSO or ethanol. Researchers typically prepare a high-concentration stock in DMSO before diluting into aqueous buffers.

How should solid lyophilized Dihexa be stored to preserve long-term stability?

Lyophilized powder should be stored desiccated at -20°C for routine short-term storage or -80°C for extended periods. Reconstituted stock solutions should be stored in single-use aliquots at -20°C.

How does Dihexa compare to other neuroplasticity peptides like Semax?

While Semax targets neurotrophin expression like BDNF, Dihexa acts as a direct HGF potentiator via the c-Met tyrosine kinase receptor, exhibiting higher enzymatic stability due to its peptidomimetic structure.

What endotoxin limits are maintained for PX1 Research compounds?

All PX1 Research compounds undergo LAL assay testing to confirm endotoxin levels below 0.01 EU/mg, preventing cell culture contamination and false non-specific inflammatory signaling.

Can Dihexa be purchased for bulk institutional or academic laboratory studies?

Yes, university laboratories and corporate research institutes can establish institutional research accounts via PX1 Research to access bulk tier pricing and custom lot reservations.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.